EGFR and neoplasm: Despite the difference in mutation frequencies between sporadic and hereditary breast cancers, it is obvious that sporadic and heritable breast cancers both have a similarly high frequency of EGFR mutations in tumour stroma, and that the majority of missense mutations lie in exon 20, in contrast to those in NSCLC.